BioCentury
ARTICLE | Company News

Impax management update

July 1, 2013 7:00 AM UTC

Impax Laboratories Inc. (NASDAQ:IPXL), Hayward, Calif. Business: Drug delivery, Neurology, Generics Retiring: Larry Hsu as president and CEO, while remaining a director, effective after a replacement ...